In skeletal muscle, FOXO1 upregulates atrophy-related genes such as Atrogin1 and MuRF1, thereby promoting muscle protein degradation and contributing to sarcopenia (Sandri et al., 2004; O’Neill et al., 2018). This evidence concerns the gene FOXO1 and sarcopenia.